Literature DB >> 9721039

Reduction of tyrosine nitration after N(omega)-nitro-L-arginine-methylester treatment of mice with traumatic brain injury.

C Mésenge1, C Charriaut-Marlangue, C Verrecchia, M Allix, R R Boulu, M Plotkine.   

Abstract

Oxygen free radicals and nitric oxide (NO) have been proposed to be involved in the cascade of injury elicited by traumatic brain injury. However, the mechanism(s) of injury remain to be explored. Since superoxide generation is triggered by traumatic brain injury, the cytotoxic peroxynitrite could be formed, but it is not known if this actually occurs. Dot blot and immunohistochemistry studies were performed to quantify tyrosine nitration and identify cell types in which such reactions occur in the brain of mice submitted to traumatic brain injury. Nitrotyrosine formation increased from 4 to 24 h after traumatic brain injury and was primarily observed in degenerating neurons, in areas corresponding to the sites of direct impact (frontal cortex) and diffuse impact (frontoparietal cortex and ventromedial hypothalamic nucleus). Furthermore, N omega-nitro-L-arginine-methylester (L-NAME), a NO-synthase inhibitor which has previously been shown to promote neurological recovery in traumatic brain injury, reduced nitrotyrosine formation and the number of nitrotyrosine-positive neurons. These results indicate that traumatic brain injury induces peroxynitrite formation which may contribute to cell damage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721039     DOI: 10.1016/s0014-2999(98)00432-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  Is glucose-6-phosphate dehydrogenase deficiency a risk factor for hyperbaric oxygen exposure?

Authors:  Mirit Eynan; Dimitry Tsitlovsky; Liron Batit; Ayala Hochman; Nitzan Krinsky; Amir Abramovich
Journal:  Eur J Appl Physiol       Date:  2011-11-11       Impact factor: 3.078

2.  Changes of nitric oxide and its relationship with clinical features, intracranial pressure and outcome in acute head injury.

Authors:  D Zhou; M Qiu; Y Guan; L Li
Journal:  J Tongji Med Univ       Date:  2000

Review 3.  Antioxidant therapies for traumatic brain injury.

Authors:  Edward D Hall; Radhika A Vaishnav; Ayman G Mustafa
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

4.  Neuroproteomic study of nitrated proteins in moderate traumatic brain injured rats treated with gamma glutamyl cysteine ethyl ester administration post injury: Insight into the role of glutathione elevation in nitrosative stress.

Authors:  Moses Henderson; Brittany Rice; Andrea Sebastian; Patrick G Sullivan; Christina King; Renã A S Robinson; Tanea T Reed
Journal:  Proteomics Clin Appl       Date:  2016-11-11       Impact factor: 3.494

Review 5.  Antioxidant therapies in traumatic brain and spinal cord injury.

Authors:  Mona Bains; Edward D Hall
Journal:  Biochim Biophys Acta       Date:  2011-11-04

6.  Relationship of nitric oxide synthase induction to peroxynitrite-mediated oxidative damage during the first week after experimental traumatic brain injury.

Authors:  Edward D Hall; Juan A Wang; Darren M Miller
Journal:  Exp Neurol       Date:  2012-08-28       Impact factor: 5.330

Review 7.  Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.

Authors:  Valerie C Besson
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

8.  Traumatic brain injury in vivo and in vitro contributes to cerebral vascular dysfunction through impaired gap junction communication between vascular smooth muscle cells.

Authors:  Guang-Xiang Yu; Martin Mueller; Bridget E Hawkins; Babu P Mathew; Margaret A Parsley; Leoncio A Vergara; Helen L Hellmich; Donald S Prough; Douglas S Dewitt
Journal:  J Neurotrauma       Date:  2014-01-31       Impact factor: 5.269

Review 9.  Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury.

Authors:  Clifford L Eastman; Raimondo D'Ambrosio; Thota Ganesh
Journal:  Neuropharmacology       Date:  2019-12-06       Impact factor: 5.250

Review 10.  Protein accumulation in traumatic brain injury.

Authors:  Douglas H Smith; Kunihiro Uryu; Kathryn E Saatman; John Q Trojanowski; Tracy K McIntosh
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.